Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ONCI getting a little lovin' this morning :)
A $15 sale (1000 shares) to drop it from .0175 to .015 That is totally MM K-Rap...
Nobody would spend the commission to do that..
Well as far as I can tell, dilution wasn't what caused the price drop and that seems to be being dealt with accordingly. Will see.. it would have to drop 20% from here to knock me out of the saddle. so, till then I'm holding.
Yeah, just keep a good eye on that float..Are you holding here or just "lurking" ??
You-Go Bigbug1..I need some cheapies : )
BS trade 1000 shares .011 MM Bull 29%red
Need Volume..
Regular Dummy still here ; )
Looks like they are diluting to raise cash.
Simply the bet penny stock alerts SVEN link which gives you the same link as PennyStockInsiders e-mail link
Simply the best penny stock alerts
APS pick link...
APS pick is SVEN
Profit ; ) Sooo, what's your "profit point" now? I've "profited" back to .01976 avg so it's not tooo bad as yet...
I'd be interested to know if the sellers are just "Peeps" or if it's the company or their creditors ?
Anything less than 1/2cent here is ridiculously cheap..
At least they are not slipping in sells under the bid price like they were doing the other day...
Yes, in anticipation as the successful launch comes closer of the 4.0 commercial version of the DiMi M2M communications platform. Not to mention "Green Genie" just getting a foothold now... and when this thing does "move" it's gonna rock as has been witnessed already...
Hallelujah.. Hopefully it's a trend : )
Sorry for my recent bid whacking but I finally got my avg down to .0204 Figured they would cover some shorts low... Ok, i'm done now : ) I will be holding for the Spring Breakout : )
GRRRRWhackin' : ( Hey, whatever..it'll happen w/time..
There's still interest here from the looks of it. I really like the way this can move like it did of it's own volition.. Imagine when the update hits : )
Amarantus BioSciences Secures $1.1 Million in Financing
Last update: 11/14/2012 2:53:00 PMConvertible Note investment into the Company priced at $0.10 per share SUNNYVALE, Calif., Nov. 14, 2012 /PRNewswire via COMTEX/ -- Amarantus BioSciences, Inc. (otcqb:AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced it has secured over $1.1 million in funding through two separate transactions. Proceeds will be used to provide funding for the Company's lead asset, Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF"), reconcile certain of Amarantus' outstanding payables, and for general working capital. "Amarantus is at a pivotal stage in our corporate development, and these transactions provide us with capital to advance our research collaborations, continue our efforts to progress MANF into clinical trials, as well as strengthen the Company's balance sheet, making the Company more attractive to the investment community," said Gerald E. Commissiong, President and CEO of Amarantus. "Interim data for MANF showed promising results in behavioural animal models of Parkinson's disease, and we expect final data to be available in December. With this financing, the Company can make more substantial progress with our product candidates, allowing management to market the MANF opportunity to potential partners as well as look at creative financing structures to ensure MANF and NuroPro's further development. We remain focused on moving our Parkinson's assets towards clinical trials to explore the potential benefits for patients, and we will also begin to explore additional applications for the MANF technology which may address larger markets, and/or address smaller orphan drug markets that have more rapid paths to commercialization." Amarantus issued a Convertible Promissory Note to an undisclosed institutional investor (the "Investor") in the principal amount of $600,000. The Note bears interest at the rate of ten percent (10%) per annum until paid in full and can convert into shares of the Company's common stock at a price of $0.10 per share, subject to certain provisions. The note is not convertible into common shares for 6 months, and the Company has the option to pay the note in cash at its discretion at any time. Monies will be paid to Amarantus under the note in four separate tranches of $150,000 over a 6 week period, subject to certain milestones. The Investor agreed to "no shorting" provisions. Amarantus entered into an unrelated equity financing arrangement with a separate long-only institutional fund (the "Fund") that assists public companies in financing operations and expansion. The Company settled over $500,000 in accounts payable, which the fund had acquired from various creditors of the Company, in exchange for shares of common stock. The transaction substantially reduced the Company's liabilities, including a portion of its outstanding accounts payable balance. The Fund agreed to "no shorting" provisions. About Amarantus BioSciences, Inc. Amarantus BioSciences, Inc. is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, Traumatic Brain Injury and other human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. The Company also is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. For further information please visit . Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the possible benefits of MANF therapeutic applications and/or advantages presented by Amarantus' PhenoGuard technology, as well as statements about expectations, plans and prospects of the development of Amarantus' new product candidates. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including the risks that the anticipated benefits of the therapeutic drug candidates or discovery platforms, as well as the risks, uncertainties and assumptions relating to the development of Amarantus' new product candidates, including those identified under "Risk Factors" in Amarantus' most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q and in other filings Amarantus periodically makes with the SEC. Actual results may differ materially from those contemplated by these forward-looking statements Amarantus does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation. This press release does not represent an offer to buy or sell securities. Amarantus BioSciences, Inc.(408) 737-2734pr@amarantus.com Investor/Media Contact:IR Sense, LLCRemy Bernarda415-203-6386remy@irsense.com SOURCE Amarantus BioSciences, Inc. Copyright (C) 2012 PR Newswire. All rights reserved
Yeah NITE's had the largest blocks on bid and now ask all day..
Kinda hate to see that ceiling @.005 he put there from buying all those cheapie's as it was clear to .007 earlier... and that 100K bid he has @.004 is backed by at least 300K @.0037
I hope they paint that 10,000 shares @.005 @close.. this is sooo gonna rock when it's time comes and I don't think it'll be that long. Bottom feeders should be having a blast here : )
I Reiterate
I would think that they want it to go up a bit but I think they are more interested in the liquidity of this stock at it's present price.
Doesn't look like anyone is dumb enough to fall for those bid whacks.. 400K here they ain't gonna get until this stabilizes in it's fair value price area... it's only a bit of a "dark" period at the moment with little interest due to lack of pr's..
My pockets aren't that deep... Go GYST
Yeah the caption was "Hell yeah I'm gonna sniff it..I'm a dog, it's what I do" : )
Go GYST w/o dilution ...
Ashers 3.8m was just a blip on the screen...
ps, ain't bashing , still holding shares...
Asher didn't have 40mm shares...
No link in I-Box to ON4 ? One here..
On4 Communications, Inc. (ONCI)
Continued silence is not helping..PR me : )
No patience.. Hope the seller didn't lose too much (NOT!!!)
Yeah good luck with that .004's bid..It won't be any of my shares if you did acquire some on an insane dip and got them, but in the spirit of things GLTUA
Looks like they are "Low balling" the bid and it keeps climbing with no hits.. Hope nobody suckers in for less than .01
Yeah, got my cheapies : )